“…6 Thus, alternative formulations of platinum compounds have been studied, in particular, drug delivery systems (DDSs) formed by organic macromolecules, [7][8][9] liposomes, 10,11 nanoparticles 12,13 and oxidized carbon nanocomposites. [14][15][16][17][18][19][20] Once in the bloodstream, it is expected that these systems are able to protect the drug against undesirable side reactions as well as provide efficient release in a controlled biological target. Therefore, the understanding of how these systems are provided as inclusion compounds can contribute to design improved complexes with desirable properties.…”